{
  "id": "83fc9929-4538-4c36-8d98-d228bfb09e16",
  "title": "Centene Stock Plunges After Company Pulls Guidance",
  "link": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-07-02-2025/card/centene-stock-plunges-after-company-pulls-guidance-iwkA5f64JhVJAgaJLMoP?siteid=yhoof2\u0026yptr=yahoo",
  "description": "",
  "author": "",
  "published": "2025-07-02T13:32:33Z",
  "source": "https://finance.yahoo.com/news/rssindex",
  "categories": null,
  "byline": "ByAnna Wilde Mathews, Reporter",
  "length": 898,
  "excerpt": "Managed-care specialist Centene withdrew financial guidance for 2025, warning that earnings will fall well short of expectations. Its shares tumbled. Centene's move comes after industry bellwether UnitedHealth pulled its guidance for the year and replac",
  "siteName": "WSJ",
  "favicon": "https://s.wsj.net/media/wsj_apple-touch-icon-180x180.png",
  "text": "Centene Stock Plunges After Company Pulls GuidanceManaged-care specialist Centene withdrew financial guidance for 2025, warning that earnings will fall well short of expectations. Its shares tumbled.Centene's move comes after industry bellwether UnitedHealth pulled its guidance for the year and replaced its chief executive. It is likely to add to investors’ nervousness about the entire insurance sector, which has felt the effect of higher-than-expected medical costs. Humana and CVS Health’s Aetna struggled last year, with CVS also bringing on a new CEO.Centene focuses largely on Medicaid and the Affordable Care Act insurance marketplaces. It said it recently got data showing that enrollees in the marketplaces overall appeared fewer, and less healthy, than expected. As a result, the company expects to get a smaller payout from a federal program designed to even out risk across insurers.",
  "image": "https://images.wsj.net/im-02066273",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv data-id=\"StreamBody_index_MainContainer\"\u003e\u003cdiv\u003e\u003cp\u003e\u003ch3 data-id=\"Headline_index_TextBlock\"\u003eCentene Stock Plunges After Company Pulls Guidance\u003c/h3\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv data-id=\"LiveCoverageCard_index_CardBlock\"\u003e\u003cp\u003eManaged-care specialist \u003ca href=\"https://www.wsj.com/market-data/quotes/CNC\"\u003eCentene\u003c/a\u003e withdrew financial guidance for 2025, warning that earnings will fall well short of expectations. Its shares tumbled.\u003c/p\u003e\u003cp\u003eCentene\u0026#39;s move comes after industry bellwether UnitedHealth pulled its guidance for the year and replaced its chief executive. It is likely to add to investors’ nervousness about \u003ca href=\"https://www.wsj.com/livecoverage/stock-market-today-dow-sp500-nasdaq-live-12-12-2024/card/centene-ceo-says-health-insurers-are-operating-in-unprecedented-times--yi3QZUVQBQVyFwuAVUti\"\u003ethe entire insurance sector\u003c/a\u003e, which has felt the effect of higher-than-expected medical costs. Humana and CVS Health’s Aetna struggled last year, with CVS also bringing on a new CEO.\u003c/p\u003e\u003cp\u003eCentene focuses largely on Medicaid and the Affordable Care Act insurance marketplaces. It said it recently got data showing that enrollees in the marketplaces overall appeared fewer, and less healthy, than expected. As a result, the company expects to get a smaller payout from a federal program designed to even out risk across insurers.\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "2 min read",
  "publishedTime": null,
  "modifiedTime": null
}
